Immune reconstitution after autologous purged bone marrow transplantation in children

Naynesh Kamani, Antonis Kattamis, Aaron Carroll, Donald Campbell, Nancy Bunin

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: Immune reconstitution was studied in 30 children who had received purged autologous bone marrow transplantation for neuroblastoma or acute myeloid leukemia (AML). Methods: Patients with neuroblastoma received high-dose chemotherapy and total body irradiation, and patients with AML received chemotherapy alone. Marrows were purged ex vivo with either antineuroblastoma monoclonal antibodies (neuroblastoma) or 4-hydroperoxycyclophosphamide (AML). Lymphocyte subsets, mitogen stimulation studies, and immunoglobulin levels were studied every 4 months. Results: There were no significant differences between the two groups of patients in lymphocyte number or subsets over time. In both groups, CD2+ and CD4+ cells were below normal in 33% of patients at 12 months. CD4+/CD8+ ratios were below normal for up to 8 months after transplantation and natural killer cells were elevated for up to 2 years in most patients. Median IgG and IgA levels were below the age mean even at 2 years after transplantation, although patients with AML had significantly higher IgG levels at 12 months compared with those with neuroblastoma. Lymphocyte proliferative responses to mitogens were markedly reduced at 4 months but returned to normal at 8 months. Despite the delay in immune reconstitution, there were no life-threatening infections. Conclusions: There appeared to be little difference in the overall kinetics of immune reconstitution between the children with neuroblastoma, who received total body irradiation and high-dose chemotherapy, and those with AML, who received high-dose chemotherapy alone as their pretransplant preparative regimen.

Original languageEnglish (US)
Pages (from-to)13-19
Number of pages7
JournalAmerican Journal of Pediatric Hematology/Oncology
Volume22
Issue number1
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Bone Marrow Transplantation
Neuroblastoma
Acute Myeloid Leukemia
Drug Therapy
perfosfamide
Whole-Body Irradiation
Lymphocyte Subsets
Mitogens
Immunoglobulin G
Transplantation
CD4-CD8 Ratio
Autologous Transplantation
Lymphocyte Count
Natural Killer Cells
Immunoglobulin A
Immunoglobulins
Bone Marrow
Monoclonal Antibodies
Lymphocytes
Infection

Keywords

  • Autologous
  • Immune reconstitution
  • Lymphocytes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Immune reconstitution after autologous purged bone marrow transplantation in children. / Kamani, Naynesh; Kattamis, Antonis; Carroll, Aaron; Campbell, Donald; Bunin, Nancy.

In: American Journal of Pediatric Hematology/Oncology, Vol. 22, No. 1, 01.01.2000, p. 13-19.

Research output: Contribution to journalArticle

Kamani, Naynesh ; Kattamis, Antonis ; Carroll, Aaron ; Campbell, Donald ; Bunin, Nancy. / Immune reconstitution after autologous purged bone marrow transplantation in children. In: American Journal of Pediatric Hematology/Oncology. 2000 ; Vol. 22, No. 1. pp. 13-19.
@article{3f42d2ff362f4e92b639e58be9948101,
title = "Immune reconstitution after autologous purged bone marrow transplantation in children",
abstract = "Purpose: Immune reconstitution was studied in 30 children who had received purged autologous bone marrow transplantation for neuroblastoma or acute myeloid leukemia (AML). Methods: Patients with neuroblastoma received high-dose chemotherapy and total body irradiation, and patients with AML received chemotherapy alone. Marrows were purged ex vivo with either antineuroblastoma monoclonal antibodies (neuroblastoma) or 4-hydroperoxycyclophosphamide (AML). Lymphocyte subsets, mitogen stimulation studies, and immunoglobulin levels were studied every 4 months. Results: There were no significant differences between the two groups of patients in lymphocyte number or subsets over time. In both groups, CD2+ and CD4+ cells were below normal in 33{\%} of patients at 12 months. CD4+/CD8+ ratios were below normal for up to 8 months after transplantation and natural killer cells were elevated for up to 2 years in most patients. Median IgG and IgA levels were below the age mean even at 2 years after transplantation, although patients with AML had significantly higher IgG levels at 12 months compared with those with neuroblastoma. Lymphocyte proliferative responses to mitogens were markedly reduced at 4 months but returned to normal at 8 months. Despite the delay in immune reconstitution, there were no life-threatening infections. Conclusions: There appeared to be little difference in the overall kinetics of immune reconstitution between the children with neuroblastoma, who received total body irradiation and high-dose chemotherapy, and those with AML, who received high-dose chemotherapy alone as their pretransplant preparative regimen.",
keywords = "Autologous, Immune reconstitution, Lymphocytes",
author = "Naynesh Kamani and Antonis Kattamis and Aaron Carroll and Donald Campbell and Nancy Bunin",
year = "2000",
month = "1",
day = "1",
doi = "10.1097/00043426-200001000-00003",
language = "English (US)",
volume = "22",
pages = "13--19",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Immune reconstitution after autologous purged bone marrow transplantation in children

AU - Kamani, Naynesh

AU - Kattamis, Antonis

AU - Carroll, Aaron

AU - Campbell, Donald

AU - Bunin, Nancy

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Purpose: Immune reconstitution was studied in 30 children who had received purged autologous bone marrow transplantation for neuroblastoma or acute myeloid leukemia (AML). Methods: Patients with neuroblastoma received high-dose chemotherapy and total body irradiation, and patients with AML received chemotherapy alone. Marrows were purged ex vivo with either antineuroblastoma monoclonal antibodies (neuroblastoma) or 4-hydroperoxycyclophosphamide (AML). Lymphocyte subsets, mitogen stimulation studies, and immunoglobulin levels were studied every 4 months. Results: There were no significant differences between the two groups of patients in lymphocyte number or subsets over time. In both groups, CD2+ and CD4+ cells were below normal in 33% of patients at 12 months. CD4+/CD8+ ratios were below normal for up to 8 months after transplantation and natural killer cells were elevated for up to 2 years in most patients. Median IgG and IgA levels were below the age mean even at 2 years after transplantation, although patients with AML had significantly higher IgG levels at 12 months compared with those with neuroblastoma. Lymphocyte proliferative responses to mitogens were markedly reduced at 4 months but returned to normal at 8 months. Despite the delay in immune reconstitution, there were no life-threatening infections. Conclusions: There appeared to be little difference in the overall kinetics of immune reconstitution between the children with neuroblastoma, who received total body irradiation and high-dose chemotherapy, and those with AML, who received high-dose chemotherapy alone as their pretransplant preparative regimen.

AB - Purpose: Immune reconstitution was studied in 30 children who had received purged autologous bone marrow transplantation for neuroblastoma or acute myeloid leukemia (AML). Methods: Patients with neuroblastoma received high-dose chemotherapy and total body irradiation, and patients with AML received chemotherapy alone. Marrows were purged ex vivo with either antineuroblastoma monoclonal antibodies (neuroblastoma) or 4-hydroperoxycyclophosphamide (AML). Lymphocyte subsets, mitogen stimulation studies, and immunoglobulin levels were studied every 4 months. Results: There were no significant differences between the two groups of patients in lymphocyte number or subsets over time. In both groups, CD2+ and CD4+ cells were below normal in 33% of patients at 12 months. CD4+/CD8+ ratios were below normal for up to 8 months after transplantation and natural killer cells were elevated for up to 2 years in most patients. Median IgG and IgA levels were below the age mean even at 2 years after transplantation, although patients with AML had significantly higher IgG levels at 12 months compared with those with neuroblastoma. Lymphocyte proliferative responses to mitogens were markedly reduced at 4 months but returned to normal at 8 months. Despite the delay in immune reconstitution, there were no life-threatening infections. Conclusions: There appeared to be little difference in the overall kinetics of immune reconstitution between the children with neuroblastoma, who received total body irradiation and high-dose chemotherapy, and those with AML, who received high-dose chemotherapy alone as their pretransplant preparative regimen.

KW - Autologous

KW - Immune reconstitution

KW - Lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0034457789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034457789&partnerID=8YFLogxK

U2 - 10.1097/00043426-200001000-00003

DO - 10.1097/00043426-200001000-00003

M3 - Article

C2 - 10695816

AN - SCOPUS:0034457789

VL - 22

SP - 13

EP - 19

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -